The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance.
Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.
1. Cover image - p. c 2. Title page - p. i 3. Copyright - p. ii 4. Contents - p. v 5. Contributors - p. xiii 6. About the editors - p. xvii 7. Chapter 1 Understanding the microbiome: Microbiome and immune system interactions - p. 1 8. Chapter 2 The microbiome: Its impact on cancer development and therapeutic responses - p. 37 9. Chapter 3 Microbiome dynamics in cancer treatment: Impact of chemotherapy on the microbiome - p. 71 10. Chapter 4 Microbiome as a modulator of immunotherapy: Synergistic effects of the microbiome in immunotherapy - p. 105 11. Chapter 5 Microbiome-based strategies to overcome chemoresistance: Probiotics and prebiotics in cancer therapy - p. 129 12. Chapter 6 Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy - p. 165 13. Chapter 7 The impact of the microbiome on resistance to cancer treatment with chemotherapeutic agents and immunotherapy - p. 193 14. Chapter 8 Cancer pharmacomicrobiomics: Targeting microbiota to optimize cancer therapy outcomes - p. 227 15. Chapter 9 Gut microbiome in modulating immune checkpoint inhibitors - p. 263 16. Chapter 10 Microbiome-based diagnostics and biomarkers: The search for mechanistic connections - p. 293 17. Chapter 11 Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors - p. 335 18. Chapter 12 Current challenges and future prospects for microbiome research in cancer treatment - p. 361 19. Index - p. 389
The Microbiome and Cancer Treatment: Overcoming Resistance and Enhancing Efficacy delves into the intricate relationship between the microbiome and cancer treatment, highlighting the microbiome's critical role in drug resistance and therapeutic efficacy. The book's chapters are meticulously organized to provide a deep understanding of how the microbiome interacts with the immune system and influences cancer development and response to therapies. This book opens new avenues for investigation by providing a better understanding of the mechanisms of resistance and the role of microbiome alterations in chemoresistance.
Sections also address the complex "chicken-or-egg" relationship between microbiome alterations and chemoresistance. A diverse blend of chapters foster interdisciplinary collaboration across fields such as immunology, microbiology, oncology, and pharmacology, promoting holistic approaches to cancer treatment. Readers will benefit by gaining awareness and a better understanding of how the microbiome impacts health, particularly in the context of cancer, leading to more informed health choices.
1. Cover image - p. c 2. Title page - p. i 3. Copyright - p. ii 4. Contents - p. v 5. Contributors - p. xiii 6. About the editors - p. xvii 7. Chapter 1 Understanding the microbiome: Microbiome and immune system interactions - p. 1 8. Chapter 2 The microbiome: Its impact on cancer development and therapeutic responses - p. 37 9. Chapter 3 Microbiome dynamics in cancer treatment: Impact of chemotherapy on the microbiome - p. 71 10. Chapter 4 Microbiome as a modulator of immunotherapy: Synergistic effects of the microbiome in immunotherapy - p. 105 11. Chapter 5 Microbiome-based strategies to overcome chemoresistance: Probiotics and prebiotics in cancer therapy - p. 129 12. Chapter 6 Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy - p. 165 13. Chapter 7 The impact of the microbiome on resistance to cancer treatment with chemotherapeutic agents and immunotherapy - p. 193 14. Chapter 8 Cancer pharmacomicrobiomics: Targeting microbiota to optimize cancer therapy outcomes - p. 227 15. Chapter 9 Gut microbiome in modulating immune checkpoint inhibitors - p. 263 16. Chapter 10 Microbiome-based diagnostics and biomarkers: The search for mechanistic connections - p. 293 17. Chapter 11 Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors - p. 335 18. Chapter 12 Current challenges and future prospects for microbiome research in cancer treatment - p. 361 19. Index - p. 389
